chr10-27155458-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001172303.3(MASTL):c.32C>T(p.Pro11Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,054 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001172303.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MASTL | NM_001172303.3 | c.32C>T | p.Pro11Leu | missense_variant | 1/12 | ENST00000375940.9 | NP_001165774.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MASTL | ENST00000375940.9 | c.32C>T | p.Pro11Leu | missense_variant | 1/12 | 1 | NM_001172303.3 | ENSP00000365107 | P5 | |
MASTL | ENST00000375946.8 | c.32C>T | p.Pro11Leu | missense_variant | 1/12 | 1 | ENSP00000365113 | A1 | ||
MASTL | ENST00000342386.10 | c.32C>T | p.Pro11Leu | missense_variant | 1/11 | 2 | ENSP00000343446 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000294 AC: 43AN: 1460856Hom.: 0 Cov.: 34 AF XY: 0.0000248 AC XY: 18AN XY: 726676
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74352
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 11, 2023 | The c.32C>T (p.P11L) alteration is located in exon 1 (coding exon 1) of the MASTL gene. This alteration results from a C to T substitution at nucleotide position 32, causing the proline (P) at amino acid position 11 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at